Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Ann Hematol ; 101(11): 2507-2513, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-36094534

RESUMEN

The complexity and costs of hematopoietic cell transplantation (HCT) have increased over the last decades with the popularization of unrelated donor (URD) transplantation and the introduction of haploidentical transplantation with posttransplant cyclophosphamide. Few studies have addressed this issue. The objective of this study was to analyze HCT costs in a single FACT-accredited private non-profit hospital. We included 79 patients who underwent HCT between 2018 and 2020. We have included all costs from admission day until D + 180. We used a lognormal regression. Median age was 53 y/o and most donors were unrelated (51%). Costs were higher with haploidentical donor (42%, p = 0.017, compared with URD), higher HCT-CI (15% for each point, p = 0.0056), and in patients with liver or gastrointestinal GVHD (45%, p = 0.033), and lower in patients who received CD34 > 2.5 × 10E6/kg (42%, p = 0.0038). We built a score based on the following risk factors: HCT-CI > 3, CD34 ≤ 2.5 × 10E6/kg, haploidentical donor, and donor age > 30 y/o. Patients with 2 + risk factors (N = 53) had a median cost of USD 226,156.00, compared with USD 93,048.00 in patients with zero or 1 point (N = 26, p < 0.0001). In summary, we have shown that HCT costs are higher with lower doses of CD34 cells, haploidentical HCT (provided that the costs of stem cell procurement and ATG are not included), and in patients with higher HCT-CI. Prospective and refined cost analyses comparing haploidentical and URD transplants, as well as effective strategies for patients with higher HCT-CI scores, are warranted. We found no difference in costs between URD and MSD transplantation.


Asunto(s)
Enfermedad Injerto contra Huésped , Trasplante de Células Madre Hematopoyéticas , Brasil , Ciclofosfamida , Estrés Financiero , Enfermedad Injerto contra Huésped/etiología , Enfermedad Injerto contra Huésped/prevención & control , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Humanos , Persona de Mediana Edad , Estudios Prospectivos , Estudios Retrospectivos , Factores de Riesgo , Hermanos , Acondicionamiento Pretrasplante , Donante no Emparentado
2.
Eur J Clin Invest ; 51(2): e13379, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-32959899

RESUMEN

BACKGROUND: In haematopoietic cell transplantation (HCT), oral mucositis and xerostomia are related to conditioning-related oxidative stress. The role of salivary antioxidant enzymes in oral toxicity is poorly described. The aim of this study was to verify the association between salivary antioxidant enzymes and oral mucositis and xerostomia in HCT. DESIGN: Saliva from autologous and allogeneic HCT patients (n = 77) was selected before conditioning (T0), during the neutropenia period (T1) and after marrow engraftment (T2). Salivary flow, total salivary proteins, and superoxide dismutase, catalase and glutathione reductase activities were measured. RESULTS: There were no significant differences in salivary flow, total salivary proteins and catalase at the three HCT time points. Glutathione reductase levels were reduced at T1 compared to T0 (P = .013) and T2 (P = .001). Superoxide dismutase levels were increased from T0 to T2 (P = .013). Neither of these enzymes was associated with oral mucositis. Increased superoxide dismutase levels were associated with xerostomia frequency. Levels of this enzyme also showed significant correlation with days of xerostomia in T2 (ρ = .40, P = .002). CONCLUSIONS: Salivary antioxidant enzymes changed before and during early periods after HCT. The increase in salivary superoxide dismutase suggested partial activation of the salivary antioxidant system and was associated with xerostomia.


Asunto(s)
Catalasa/metabolismo , Glutatión Reductasa/metabolismo , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Saliva/enzimología , Estomatitis/metabolismo , Superóxido Dismutasa/metabolismo , Acondicionamiento Pretrasplante/efectos adversos , Xerostomía/metabolismo , Adolescente , Adulto , Anciano , Antioxidantes/metabolismo , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estrés Oxidativo , Proteínas y Péptidos Salivales/metabolismo , Estomatitis/etiología , Trasplante Autólogo , Trasplante Homólogo , Xerostomía/etiología , Adulto Joven
3.
Support Care Cancer ; 29(11): 6891-6902, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34021422

RESUMEN

Photobiomodulation therapy (PBMT) has demonstrated efficacy in the prevention and treatment of oral mucositis (OM) in hematopoietic cell transplantation (HCT). However, based on the cell stimulation properties, its long-term safety has been questioned, mainly in relation to risk for secondary malignancies in the oral cavity. The aim of this study was to investigate if different PBMT protocols for OM control have association with immediate and late adverse effects in HCT patients. Data on autologous and allogeneic transplantation, conditioning regimen, PBMT protocols, and OM severity were retrospectively collected from medical and dental records. Presence of secondary malignancies in the oral cavity was surveyed during a 15-year follow-up. Impact of OM on overall survival was also analyzed. Different PBMT protocols for prevention and treatment of OM were recorded over the years. Severe OM (grades 3 and 4) was infrequently observed. When present, we observed a significant decrease of the overall survival. No immediate adverse effect and secondary malignancy was associated to PBMT. In conclusion, the PBMT protocols used in the study were considered safe. The low frequency of severe OM observed encourages the implementation of this technique, with a special emphasis on the dosimetry adjustments focused on the HCT context.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Terapia por Luz de Baja Intensidad , Estomatitis , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Humanos , Estudios Retrospectivos , Estomatitis/etiología , Acondicionamiento Pretrasplante/efectos adversos , Trasplante Homólogo
4.
Nutr Cancer ; 70(2): 241-248, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29278934

RESUMEN

The aim of this study was to evaluate whether digestive tract mucositis is a predictive factor for body weight (BW) alterations during hematopoietic stem cell transplantation (HSCT). Data about characteristics of transplantation, initial nutritional conditions and gastrointestinal mucositis were collected from adult patients (n = 105) who underwent autologous and allogeneic HSCT. Oral mucositis (OM) was not a predictive factor for BW loss, but it was an independent factor for BW gain in autologous HSCT (ß = 0.329, P = 0.021). Busulfan-fludarabine conditioning regimen (ß = 1.531, P = 0.011) and gender (ß = 1.109, P = 0.038) were significant independent risk factors for BW loss in allogeneic HSCT. Overall survival (OS) was significantly affected by the duration of OM in autologous HSCT (HR = 1.243, P = 0.008). In allogeneic HSCT, BW loss (HR = 1.308, P = 0.049) and diarrhea (HR = 1.139, P = 0.012) interfered significantly with OS. In conclusion, OM was not a risk factor for BW loss, but it influenced BW gain and had a negative impact on OS in autologous HSCT patients. Intestinal mucositis explained partially the BW loss and had a negative impact on OS in allogeneic HSCT.


Asunto(s)
Peso Corporal , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Mucositis/etiología , Acondicionamiento Pretrasplante/efectos adversos , Adulto , Anciano , Femenino , Trasplante de Células Madre Hematopoyéticas/mortalidad , Humanos , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Análisis Multivariante , Estudios Retrospectivos , Trasplante Autólogo/efectos adversos , Trasplante Homólogo/efectos adversos
5.
Pediatr Transplant ; 19(3): 316-25, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25677170

RESUMEN

OM is a painful inflammatory condition of the oral mucosa, derived from the toxic effects of chemotherapy and radiotherapy. High OM severity is frequently present in HSCT pediatric patients, who exhibit multiple painful ulcers that limit their mastication and swallowing, leading to poor nutritional status. Few studies have demonstrated OM clinical outcomes in young patients undergoing HSCT. Feasibility of oral care and LLLT on OM prophylaxis and treatment is also poorly discussed. The aim of this study was to describe a specialized oral care protocol that included LLLT for pediatric patients undergoing transplantation and to demonstrate the clinical outcomes after OM prevention and treatment. Data from OM-related morbidity were collected from 51 HSCT pediatric patients treated daily with LLLT, followed by standard oral care protocols. All the patients, even infants and young children, accepted the daily oral care and LLLT well. The majority (80.0%) only exhibited erythema in the oral mucosa, and the maximum OM degree was WHO II. Patients who had undergone autologous and HLA-haploidentical transplants showed OM with the lowest severity. The frequency of total body irradiation and methotrexate prescriptions was higher in adolescents when compared with infants (p = 0.044), and adolescents also exhibited OM more severely than infants and young children. We found that good clinical outcomes were obtained using this therapy, mainly in regard to the control of OM severity and pain reduction in the oral cavity. Specialized oral care, including LLLT, is feasible and affordable for HSCT pediatric patients, although some adaptation in the patient's oral hygiene routine must be adopted with help from parents/companions and clinical staff.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas/efectos adversos , Terapia por Láser/métodos , Rayos Láser , Terapia por Luz de Baja Intensidad/métodos , Estomatitis/diagnóstico , Estomatitis/etiología , Administración Oral , Adolescente , Estudios de Casos y Controles , Niño , Preescolar , Femenino , Humanos , Lactante , Inflamación , Masculino , Higiene Bucal , Acondicionamiento Pretrasplante , Resultado del Tratamiento
6.
Am J Infect Control ; 41(11): 997-1000, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23769833

RESUMEN

BACKGROUND: In managing hematology-oncology patients, there is a great opportunity for performing hand hygiene (HH). METHODS: Over a 4-month period, we compared HH compliance measurement by 3 different methods: direct observation, electronic handwash counter for alcohol gel, and measuring the volume of product used (alcohol gel) in a 40-bed hematology-oncology unit at a tertiary care, private hospital. RESULTS: There were 388 directly observed opportunities for HH, and the overall HH compliance rate was 84.5%. A total of 235,923 HH episodes was recorded by the electronic devices. The mean HH episodes per patient-day was 77.7. There were 91.1 mL of alcohol gel used per patient-day in the unit. The correlation and P value between the percentage of HH compliance and HH episodes per 1,000 patient-days were ρ = 0.442 and P = .076, respectively. The correlation and P value between HH episodes per patient-days and alcohol gel consumption in milliliters per patient-days were ρ = 0.142 and P = .586. CONCLUSION: HH compliance was high in this unit. Direct observation, although useful, has many drawbacks. Other measures must be considered, such as electronic devices and measurement of volume use per patient-day to stimulate health care workers to increase and sustain HH compliance.


Asunto(s)
Infección Hospitalaria/prevención & control , Recolección de Datos/métodos , Adhesión a Directriz/estadística & datos numéricos , Higiene de las Manos , Investigación sobre Servicios de Salud/métodos , Neoplasias Hematológicas , Unidades Hospitalarias , Humanos
7.
Photomed Laser Surg ; 27(1): 137-44, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18699729

RESUMEN

BACKGROUND DATA AND OBJECTIVE: Oral mucositis (OM) is one of the worst cytotoxic effects of chemotherapy and radiotherapy in patients undergoing hematopoietic cell transplantation (HCT), and it causes severe morbidity. Laser phototherapy has been considered as an alternative therapy for prevention and treatment of OM. The aim of this study was to describe the incidence and severity of OM in HCT patients subjected to laser phototherapy, and to discuss its effect on the oral mucosa. PATIENTS AND METHODS: Information concerning patient age and gender, type of basic disease, conditioning regimen, type of transplant, absence or presence of pain related to the oral cavity, OM grade, and adverse reactions or unusual events were collected from 30 patients undergoing HCT (allogeneic or autologous). These patients were given oral laser phototherapy with a InGaAIP laser (660 nm and 40 mW) daily. The data were tabulated and their frequency expressed as percentages. RESULTS: In the analysis of those with OM, it was observed that 33.4% exhibited grade I, 40% grade II, 23.3% grade III, and 3.3% grade IV disease. On the most critical post-HCT days (D+5 and D+8), it was observed that 63.3% of patients had grade I and 33.3% had grade II disease; no patients had grade III or IV disease in this period. This severity of OM was similar to that seen in other studies of laser phototherapy and OM. CONCLUSION: The low grades of OM observed in this survey show the beneficial effects of laser phototherapy, but randomized clinical trials are necessary to confirm these findings.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas/efectos adversos , Terapia por Luz de Baja Intensidad , Estomatitis/prevención & control , Estomatitis/terapia , Adolescente , Adulto , Anciano , Antineoplásicos/administración & dosificación , Niño , Femenino , Humanos , Linfoma/tratamiento farmacológico , Linfoma/terapia , Masculino , Persona de Mediana Edad , Estomatitis/etiología , Estomatitis/patología , Acondicionamiento Pretrasplante , Adulto Joven
9.
Texto & contexto enferm ; 7(2): 268-88, maio-ago. 1998.
Artículo en Portugués | LILACS, BDENF - enfermagem (Brasil) | ID: lil-275500

RESUMEN

Trata-se de um estudo fenomenológico hermenêutico, que teve por objetivo desvelar os significados do cuidado a partir da experiência vivida por crianças e pré-adolescentes. Foi desenvolvido no Saläo de Enfermagem, no Shopping Beiramar em Florianópolis, no período de 13 a 15 de maio de 1996. As descriçöes obtidas nas respostas e desenhos de 57 crianças e pré-adolescentes possibilitou a emergência dos seguintes temas: promover e dar significado à vida, expressar o ser, educar para a vida, tomar consciência de si e do meio ambiente.


Asunto(s)
Femenino , Masculino , Preescolar , Niño , Vida , Empatía , Existencialismo
10.
Rev. bras. enferm ; 54(1): 48-62, jan.-mar. 2001.
Artículo en Portugués | LILACS, BDENF - enfermagem (Brasil) | ID: lil-306167

RESUMEN

Trata-se de um estudo fenomenológico hermenêutico, que teve como objetivo desvelar os significados de cuidado a partir da experiência vivida por crianças e adolescentes vítimas da violência doméstica. Foi desenvolvido em duas Casas-Lares, em Florianópolis, que funcionam em regime de abrigo temporário e excepcional, para crianças e adolescentes do sexo masculino e feminino vítimas da violência doméstica. As descrições, obtidas nas respostas e desenhos de dezoito crianças e adolescentes do sexo feminino e masculino, possibilitou-nos caracterizar o cuidado como forma de promoção da vida, de expressão do ser, de relação com o meio ambiente e, de negação de experiências vividas e de resistência para sobreviver.


Asunto(s)
Humanos , Masculino , Femenino , Niño , Adolescente , Refugio de Emergencia , Servicios de Salud del Niño , Servicios de Salud del Adolescente , Violencia Doméstica , Maltrato a los Niños , Atención a la Salud
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA